216 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Vascular Cures Wylie Scholar Program
Vascular Cures' Wylie Scholar Program provides financial assistance to outstanding surgeons at the early stage of their careers, to help them develop as academic vascular surgeon-scientists. Vascular Cures has advanced breakthrough research since 1982.
We've established a group of 16 surgeon-scientists at 13 institutions around the country who are transforming patient care. Vascular Cures' initial research investment of $8 million has enabled another $42 million in funding —producing $50 million for research.
The Wylie Scholar Program has created a network of talented academic surgeons, many of whom have become leaders in vascular surgery and research at major medical centers throughout North America. Vascular Cures will award each Wylie Scholar $50,000 per year for up to three years, subject to an annual review by the committee. As of 2013, the award is co-sponsored by the Society for Vascular Surgery (SVS). The maximum award available for any Scholar is $150,000. Payment of awards will be made to the candidate’s institution, and the institution will be responsible for disbursing all funds and for the administration of the grant. Vascular Cures does not pay indirect costs.
The award may be used for, but is not limited to: teaching, basic or clinical research, community service, and patient care. Throughout the duration of the program, Wylie Scholars will periodically be evaluated by their respective Chief of Vascular Surgery and by Vascular Cures' Review Committee.
To be eligible for consideration, Wylie Scholar candidates must hold a full-time appointment at a medical school accredited by the Liaison Committee on Medical Education in the United States or the Committee for the Accreditation of Canadian Medical Schools in Canada. Only one nomination per institution per year will be considered. The following conditions must be met:
The candidate must be in the last year of, or have in the preceding 5 years completed a Vascular Surgery Board of the American Board of Surgery or Royal College of Physicians and Surgeons of Canada approved Vascular Surgery training.
The candidate must present convincing evidence of rigorous research training and significant research accomplishments to date.
The candidate must prepare and present a challenging research plan to be completed during the term of the award.
The candidate must have a research mentor who will be an additional resource for his or her research.
The Chairman of the Department of Surgery must guarantee that the candidate will have 40% protected time available to devote to the research investigations.
The candidate is expected to participate in the Wylie Scholar award event each year during their research grant tenure. This includes participating in a scientific interchange with Vascular Cures Board of Directors and donors. Up to $1,800 of the annual stipend may be used for travel expenses and one night of lodging.
The Wylie Scholar Awards Committee of Vascular Cures will select the Scholar and present their recommendation to the Vascular Cures Board of Directors for final approval. The key criteria for selection of the potential Wylie Scholar will be a demonstrated aptitude for and interest in vascular research, skill and promise in vascular surgery, teaching ability, and leadership qualities. Selected candidates may be personally interviewed prior to the final selection.
Applications are due by April 4, 2014 and the Scholar is announced in June.
AcademyHealth Delivery System Science Fellowship
The AcademyHealth Delivery System Science Fellowship provides a paid post-doctoral learning experience to help researchers gain more applied experience conducting research in delivery system settings. This fellowship will allow individuals to enhance and apply their analytic skills to relevant and timely research topics. In 2014, placements are being offered at 10 host sites: Cleveland Clinic, Geisinger Health System, Hofstra North Shore-LIJ School of Medicine, Intermountain Healthcare, Kaiser Permanente Southern California, Mayo Clinic, Medica Research Institute, Palo Alto Medical Foundation Research Institute, the U.S. Department of Veterans Affairs Quality Enhancement Research Initiative (QUERI) and Health Services Research and Development Service (HSR&D), and the University of California Center for Health Quality and Innovation.
Researchers with a doctoral degree in health services research or a related field are encouraged to apply. Please note, applicants may apply for the fellowship if he/she will receive a doctoral degree before the fellowship start date, which is expected to be in August of 2014. More experienced candidates considering a career shift will also be considered.
While level of support and benefits will be determined by individual host sites, the minimum level of support will reflect NRSA stipend guidelines.
For more information about the fellowship and to apply, please visit http://www.academyhealth.org/Training/content.cfm?ItemNumber=9142&navItemNumber=9884.
Those who are interested in applying should submit a short statement of intent http://www.academyhealth.org/Applications/Forms/FormDisplay.cfm?FormID=48421 online.
Once the form has been submitted, candidates will immediately receive a link to the application form, which will require the submission of the writing sample, CV, and statement of interest. The application deadline is January 14, 2014.
If you have any questions, please contact email@example.com.
FSH Society Research Grants and Fellowships
We are the world's largest and most progressive grassroots network of facioscapulohumeral muscular dystrophy (FSHD) patients, their families and research activists. The FSH Society harnesses the power and insight of a patient-driven model, as it was founded on a promise between two research scientists with FSHD never to let the disease be forgotten or neglected. We are a cause without borders.
FSH Society research and fellowship grant awards provide vital start-up funding for investigators in FSHD and research projects on FSHD. The research milestones and insights gained are demonstrably significant.
The fellowship program allows innovative and entrepreneurial research to develop and ultimately to be able to attract funding from large funding sources such as the US National Institutes of Health (NIH). The FSH Society meets an important need in funding and developing new ideas and supporting new investigators in FSHD research by giving them the funds needed to develop data and to carry their ideas to the next stage of development. Without the FSH Society research and fellowships program, many key initiatives in FSHD research might never have had the chance to begin. Well over 300 peer-reviewed papers have been published by FSH Society-funded researchers.
Since 1998, the FSH Society has transformed FSHD research. The field is on the verge of significant breakthroughs. It is essential to fund new ideas and support new investigators and new lines of investigation when tackling a disease as complex as FSHD.
Deadlines for receipt of grant, research fellowship and postdoctoral fellowship applications are February 28/29 and August 31 of each year.
American Society of Transplantation Transplant Research Institute Grant Program
Since 1995, the American Society of Transplantation (AST) has invested millions of dollars to spur innovative research that has dramatically enhanced the field of organ transplantation. In an effort to benefit a broader number of investigators in more creative ways, the AST established the Transplant Research Institute (TRI) for the purposes of expanding the scope, reach, and effectiveness of the AST's research program. Among its many goals, the TRI seeks to elicit novel research topics and collaborative research opportunities from its partners in both industry and academia that are critical to advancing the science and practice of transplantation.
For 2014, the AST TRI considers applications in the following grant categories:
Faculty Development Grants
Basic Science Faculty Development Grant
Clinical Science Faculty Development Grant
Basic Science Fellowship Grant
Clinical Science Fellowship Grant
Applications for TRI grants must be completed by 11:59 PM Pacific Time on Monday, December 16, 2013. The submission site will automatically close after the deadline. No applications or supplementary documents will be accepted after the submission deadline.
The funding of any grant and total number of grants awarded by the TRI is dependent upon budgetary constraints in a given year. Grants may be funded for a one- or two-year period.
Letters of recommendation with original signatures on institutional letterhead must be uploaded to the online application.
Applicants for Faculty Development Grants and sponsors of Fellowship Grants must be members of the AST. If an applicant or sponsor is not a member, he/she must submit a completed membership application prior to the submission deadline. It is expected that membership will be active before the grant recipient is selected. 2014 AST membership dues must be paid by January 1, 2014. Apply for membership here.
Recipients of an AST TRI Grant will be recognized at the World Transplant Congress, July 26-31, 2014, in San Francisco. Recipients are expected to attend the WTC and must register for the congress. Registration to the WTC is NOT included with your grant.
No indirect costs are permitted.
Grant funding is not transferable from one recipient to another.
Research should begin on July 1, 2014.
DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the TRI. Such proposals must be IRB-approved. Any responsibility will be assumed by the PI and the funded institution.
Call for Abstracts: ALS Research
Abstracts Due: 13th January, 2014
Full Application due: 3rd March, 2014
Award Announcements: July, 2014
Funding commences: 1st August, 2014
The ALS Association Research INVESTIGATOR-INITIATED RESEARCH GRANT PROGRAM supports INNOVATIVE research of high scientific merit and relevance to amyotrophic lateral sclerosis (ALS), offering investigators awards in the following categories:
The ALS Association will support research that is projected for periods of up to three (3) years. Funding for multi-year grants is committed for one (1) year only, with noncompetitive renewals conditioned upon results. These applications require strong preliminary data. Awards will be in the amount of up to $80,000 per year.
One-year awards for NEW INVESTIGATORS ENTERING THE FIELD OF ALS. Alternatively, they can be PILOT STUDIES BY ALS INVESTIGATORS. These applications do not require strong preliminary data but must emphasize innovation, scientific merit, feasibility and relevance to ALS. The maximum amount awarded is $40,000.
The Milton Safenowitz Post Doctoral Fellowship for ALS Research Awards (Spring cycle only)
The maximum amount awarded is $50,000 per year for 2 years. Eligibility is limited to those who have been a fellow for one year or less.
Request an abstract form for any of these categories from firstname.lastname@example.org. You will be notified within two weeks of the abstract submission due date whether you are eligible to submit a full application.
Ethel & Jack Hausman Clinical Research Scholars Award
The objective of the Ethel & Jack Hausman Clinical Research Scholars Award is to assist institutions in the United States (only) to foster promising clinician-investigators early in their careers and to help in their establishment as independent researchers in areas of direct relevance to cerebral palsy. The emphasis of this award is as much on research training as it is on the research itself. Candidates for the Award must either be citizens of the United States or have permanent residency status.
The Award is in the amount of $75,000 a year for each of three years. The funds can be used at the discretion of the awardee within the purposes of the Award, the broad confines of the annual approved budget and grantee institutional policy. Supplemental funding from other sources is encouraged. It is expected that Award funds will be used as necessary and appropriate to further the objectives of the Award: the conduct of a clinical research and educational program relevant to cerebral palsy. A minimal commitment of 60 percent research effort is a requirement of the Award. The clinical research program must be patient-based or a combined laboratory–patient endeavor.
Candidates for the Award will have completed their formal clinical, graduate, and/or fellowship training. Additional opportunities for formal or informal research training are strongly encouraged during the Award. Special explanation of the need for the Award is required of applicants who have completed a research career development award from government or other organizations. It is expected each Awardee will have an appointment in an academic institution and have a clearly identified sponsor who will serve as a mentor and consultant.
The bar is set high for this award. Applicants must indicate a plan for two or more scientific or clinical publications each of the three years and submission of a subsequent research grant proposal in the second year to a non-CPIRF source. Continued funding each year is contingent on meeting these milestones.
A mandatory Letter of Intent is due January 15, 2014 (see address below). When invited to submit a full proposal, the deadline for the receipt of applications is March 1, 2014.
1. The letter should not exceed one typewritten page. It should briefly summarize:
Importance of the award for one’s career development;
Relevance of the award to clinical or scientific aspects of cerebral palsy;
The research question being addressed and the research design of the proposal;
The potential impact on the applicant’s career in cerebral palsy research.
2. Include a brief CV (NIH biosketch format) of the applicant.
3. In contrast to the research awards, there are no designated research priorities within the field of cerebral palsy for the Hausman Award.
If you have any questions about the Foundation’s research grant program, please contact the Foundation at the following:
Cerebral Palsy International Research Foundation
186 Princeton Hightstown Road; Building 4; 2nd Floor
Princeton Junction, NJ 08550
HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award
The American Society of Hematology HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award will contribute to the development of the next generation of hematologists by supporting talented medical students and residents to conduct hematology research. The award program has the following objectives:
1. Support the conduct of hematology research by medical students and residents.
2. Introduce medical students and residents to the hematology research community.
3. Encourage medical students and residents to continue research careers in hematology.
The HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award is intended for medical students and residents (residents are defined as trainees who have not yet entered a hematology-related training program) in the United States, Canada, or Mexico with an interest in hematology research. The award will provide the recipient with a $5,000 stipend to conduct either a short hematological research project for a maximum of three months, or a long hematological research project between three and 12 months. The stipend will be distributed in installments, the last of which is dependent upon the receipt of the final report submitted by the recipient. All recipients will also receive $1,000 each year for two years to support attendance at the ASH Annual Meeting.
Applications are due February 21, 2014
Notification of awards May 2014
Travel Award check requests form due for first ASH Annual Meeting October 15, 2014
Short project final report due October 1, 2014
Long project final report due August 1, 2015
Travel Award check request form due for second ASH Annual Meeting October 15, 2015
Eligible applicants must:
• Submit a complete application form.
• Be a MD or DO medical student in an LCME (or its equivalent) accredited institution in the United States, Canada, or Mexico.
• Be enrolled in an ACGME or RCPSC (or their equivalent) accredited training programs in the United Stated, Canada, or Mexico and not yet entered into a hematology-related training program.
• Be enrolled and active in an educational program at the time of application and for the duration of the award term.
• Be working on a hematological project (i.e., adult hematology, pediatric hematology/oncology, hematopathology, blood banking/transfusion medicine), in either laboratory research or clinical investigation for the duration of the award term.
• Have a home research mentor who is a member in good standing of ASH at the time the application is submitted and remain a member of ASH for the duration of the HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award term.
Fellows, graduate students (including medical students who are in a combined medical or scientific masters program), MD/PhD students, PhD students, medical students or residents who have already earned a PhD in a bio-medical field, and individuals not enrolled in an educational program are ineligible for the HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award.
If you have any questions or require any additional information regarding the HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award, please contact email@example.com.
American Society of Hematology Clinical Research Training Institute
The ASH Clinical Research Training Institute is a unique year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers and offers a broad education about clinical research methods, research collaborations, statistical analysis, and managing the demands of family and career. The goal of ASH’s Clinical Research Training Institute is to produce a group of researchers armed with ideas for clinical hematology research and the tools and access to resources to make their ideas a reality.
The Clinical Research Training Institute begins with a mandatory week-long summer workshop, to be held from August 2 through August 8, 2014 in La Jolla, CA. The workshop focuses on the foundation, methodologies, and application of patient-oriented clinical research. Participants are matched with workshop faculty members and a small group, which provide participants with intensive exposure to mentorship and networking resources. Throughout the week, participants further develop their own proposed patient-oriented clinical research projects, refining and revising their plans through interaction with faculty and peers.
Each day of the summer workshop is divided into didactic sessions and small group meetings. The mornings are dedicated to lectures on patient-oriented clinical research methodology and related topics, while in the afternoons participants meet with their workshop mentors and other faculty, including biostatisticians, to work on protocol development. Informal presentations by leaders in hematology clinical research take place in the evenings.
In addition to the summer workshop, two subsequent mandatory sessions, the first at the ASH annual meeting and the second on the third Thursday in May at ASH Headquarters in Washington, DC, provide an opportunity for further interaction and mentoring throughout the year. By applying for the Clinical Research Training Institute, you agree to participate in all three segments of the program, if accepted.
There is no fee to apply to the program, and ASH will pay for the participants’ travel expenses to the summer workshop and spring meeting. Travel to and expenses at the annual meeting are the responsibility of the participant and/or their academic institution.
Highlights of the 2014 summer workshop curriculum include:
• Advantages and disadvantages of observational studies and meta-analysis
• Advice for forming and sustaining a multi-disciplinary clinical research team including basic science colleagues
• Tools for assessing the quality of clinical research in your field
• Advice on using mentoring and networking to your advantage
• Overview of the design, conduct, analysis, and interpretation of epidemiologic studies of diseases in humans
• Strategies for securing research funding from NIH institutes and foundations supporting hematology research
• Introduction to skills necessary for presenting your work to diverse audiences
• Advice on preparing research results for publication
• Overview of basic statistical terms, sample size calculation, and interpretation of results in clinical trials
• Advice on successfully interfacing with industry while maintaining research independence
• Application of translational laboratory studies to facilitate early phase I/II clinical trials
• Overview of regulatory rules governing clinical trials
• Advice on strategies for successful collaborative research in cooperative groups by junior faculty
• Formal planning of career development and aims for a successful K23, K08 application, or similar award application
• The ABCs of the genome for clinical researchers
Eligibility Review Due January 8, 2014
Application Deadline March 28, 2014
Finalists Notified June 2014
Summer Workshop August 2 - August 8, 2014
Follow-up Meeting December 2014
Final Class May 14, 2015
All eligibility review and application submissions will be sent a confirmation email. If you do not receive a confirmation email, please contact the ASH Training Coordinator at firstname.lastname@example.org, or at 202-552-4928.
The CRTI is geared toward trainees and early career faculty members in adult and pediatric hematology, hematology/oncology and hematology-related programs at academic medical centers. Eligibility criteria include:
• CRTI applicants are required to be members of ASH in good standing at the time of the eligibility review form submission, and for the duration of the CRTI program. If your 2014 dues have not been paid by 11:59 pm, Eastern, March 1, 2014, your application will be deemed ineligible. To verify your membership status, please log on to the membership section of the ASH website.*
• North American (United States, Canada, Mexico) applicants who at the time of their application AND for the duration of the CRTI program are in hematology-related fellowship training OR are junior faculty who have completed their fellowship training within the past three years. Fellowship training is defined as any sub-specialty training in hematology irrespective of whether this training is concurrent with another training program. The first faculty position is defined as the first position as an instructor (or equivalent) or assistant professor in a hematology-related discipline irrespective of whether the applicant has held a previous faculty position in a field unrelated to hematology.
• International fellow applicants who at the time of the application have received their MD within the past 12 years. OR international faculty applicants who at the time of the application have completed their fellowship training within the past five years.
• Agreement to participate in all of CRTI. Those who are chosen for CRTI are required to attend all parts of the three-part program: 1) the 2014 Summer Workshop; 2) the follow-up program that takes place at the 2014 ASH Annual Meeting; and 3) the one-day Final Class meeting held on May 14, 2015 in Washington, DC.
• Fluency in English.
• Applicants who have been accepted to the Translational Research Training in Hematology (TRTH) program are not eligible to apply for the CRTI program until after the TRTH term has been completed.
• Applicants who have been granted an ASH Scholars Award are not eligible to apply for CRTI during the research period of the awarded project.
• Applicants in their final year of training who plan to transition to another institution the following year are eligible to apply for CRTI but must state the feasibility of completing their proposed research project at the new institution. A support letter from the new institution must be provided in addition to one from the current institution.
• Studies submitted to CRTI must directly involve clinical observation of human subjects. Research projects must include the development or study of new diagnostic methods, therapies, and/or outcome measures that ultimately will benefit patients with hematologic disorders.
• Studies that will be open to enrollment before September 2014 are not eligible as are studies which will have obtained Institutional Review Board approval by the date of the CRTI.
• Studies that are exclusively laboratory based are not appropriate.
* If you need assistance with your username and password, please contact an ASH Customer Relations Representative at email@example.com.
Eligibility Review Form Requirements
Eligibility Review Forms for the 2014 application cycle will be due by 11:59 pm Eastern on January 8, 2014. Those who have fulfilled the eligibility requirements will be invited to submit a full application. An email from ASH will be sent to the applicant within one business day of receiving the application to confirm receipt. If an email is not received, the applicant should notify ASH staff immediately. Failure to notify ASH could result in the eligibility review form not being reviewed.
If you have any questions or require any additional information regarding the ASH Clinical Research Training Institute, please contact firstname.lastname@example.org.
American Society of Hematology Research Training Award for Fellows
Audience: Junior Investigator award for second and third-year fellows in the United States or Canada.
Award Amount: $55,000
Purpose: To allow fellows in training the benefit of protected time for research for one year
Audience: Senior Investigator award for fourth and fifth-year fellows in the United States or Canada
Award Amount: $55,000
Purpose: To allow fellows in training the benefit of protected time for research for one year
The ASH Research Training Award for Fellows (RTAF) is designed to encourage junior researchers in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology. The RTAF awards $55,000 to fellows in training so they will have protected time for research and is to be used primarily for salary support for the applicant. Awards are targeted to two separate groups of researchers: a Junior Investigator RTAF for second and third-year fellows (apply in years one or two of fellowship) and a Senior Investigator RTAF for fourth or fifth-year fellows (apply in years three or four of fellowship).
Up to six awards of $55,000 each will be given each year.
The goals of this program are to:
• Encourage and enable fellowship programs to provide time for research (clinical, basic science, or translational).
• Promote mentorship of hematology trainees by outstanding faculty members.
• Produce, on a yearly basis, clinician scientist candidates for academic positions.
• Provide bridging funds for trainees who need more time to generate sufficient expertise to be competitive when applying for K award funding.
The ASH Research Training Award for Fellows will grant $55,000 for a one-year period to two groups of fellows. The Junior Investigator RTAF is for second- and third-year fellows (at the time of the award), and the Senior Investigator RTAF is for fourth- or fifth-year fellows (at the time of the award) who are not yet eligible for the ASH Scholar Awards (fellow category) in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
The Research Training Award for Fellows is intended to be used primarily for salary support for the applicant. Salary includes benefits provided by applicant's institution for up to 15% of the total award amount. Additionally, up to $5,000 of the award money may be allocated for research supplies and reagents, and up to $1,000 may be allocated for travel to the ASH annual meeting (no other meetings are eligible for this allocation). Each of the non-salary support portions of the proposed budget must be accompanied by a clear justification.
Awards will be activated on July 1 and conclude on June 30 of the year following activation. Monies cannot be used toward salary/benefits for the mentor or toward an institution's overhead or indirect costs. Payments will be made to the appropriate financial officer of the institution.
All letter application submissions will be sent a confirmation email. If you do not receive a confirmation email, please contact the ASH Training Coordinator at email@example.com, or at 202-776-0544.
Applications due (received by 11:59 PM ET) January 15, 2014
Finalists interviews by study section in Washington, DC April 2014
Award notification May 2014
Award activation July 1, 2014
RTAF applicants are required to be members of ASH in good standing at the time of application, and for the duration of the RTAF program. If your 2014 dues have not been paid by 11:59 pm, Eastern, January 15, 2014, your application will be deemed ineligible. New Associate Membership applications should be submitted no later than December 1, 2013 to be processed.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at firstname.lastname@example.org.
Applications for the 2014 award cycle must be received by 11:59 PM ET on January 15, 2014.
Junior Investigator Award
First and second-year fellows may apply to fund research in years two or three of fellowship. Eligible applicants must propose research focused on a hematologic condition (solid tumor projects are not eligible).
At the time of application, the applicant must:
• Possess an MD or DO. MD-PhDs, DO-PhDs and PhDs are not eligible unless the PhD is in a non biomedical field. National Institute of Health employees are not eligible for this award.
• Continue to maintain ASH membership and remain members in good standing of ASH for the duration of the RTAF award term.
• Be a first or second-year fellow in an ACGME or RCPSC accredited hematology, hematology/oncology, or hematology-related fellowship program in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Plan to pursue an investigative career in hematology research.
• Have a mentor who is an ASH member at the time the application is submitted and remain members of ASH for the duration of the RTAF award term. If the mentor is not in a hematology related field then a supporting letter from an ASH member is required. ( Additional mentors can be recommended by members of the study section)
• Have clear and documented support of an established mentor. This person should have funding (funding may be NIH, federal, foundation, or private) or be recognized through national clinical leadership (if the project is clinical). The mentor must remain funded during the award period.
• Provide documented support from the program director for dedicated research time during the award period.
• Secure a document from appropriate institutional leaders that states that at least 75 percent of the applicant's full-time professional efforts will be devoted to research during the funded period.
• Not hold a position as an Assistant Professor or Lecturer.
At the time of the award (July 1) the applicant must:
• Have completed one year of clinical training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Be a second or third-year fellow in an ACGME or RCPSC accredited hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Continue to maintain ASH membership. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Not have any other career-development funding during the award period. Including but not limited to foundation and NIH career development, K12, K23, K01 K 8, T32), ASCO YIA, Leukemia and Lymphoma Society Clinical Scholar awards, etc.
• The RTAF is to be the recipient's main source of salary support. In the event that the recipient's salary is not fully covered by the Research Training Award for Fellows, supplementary funding from non career development awards or grants may be used to pay the balance of the recipient's salary.
• Not be accepted in the Clinical Research Training Institute or the Translational Research Training in Hematology programs during the research period of the awarded project.
• Not have accepted an ASH Scholar Award.
Criteria for selection include:
• A focus on hematology research.
• The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to, the potential for future independent clinical or laboratory investigation and commitment to a career in hematology research.
• Quality of the mentor and the plan for mentor/applicant interaction and career development.
• The significance, feasibility, and originality of the proposed hypothesis, research, and methodology.
• Availability of institutional resources to support the proposed project.
Senior Investigator Award
Third and fourth-year fellows may apply to fund research in years four and five of fellowship. Eligible applicants must propose research focused on a hematologic condition (solid tumor projects are not eligible). Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Continue to maintain ASH membership and remain members of ASH for the duration of the RTAF award term.
• Be in the third or fourth-year of a hematology, hematology/oncology, or hematology-related fellowship in the United States or Canada.
• Have clear and documented support of a funded mentor (funding may be NIH, federal, foundation, or private) or have a mentor recognized through national clinical leadership (if the project is clinical). The mentor must remain funded during the award period.
• Have a mentor who is an ASH member at the time the letter of intent is submitted, and remain members of ASH for the duration of the RTAF award term. If the research mentor is not in a hematology related field then a supporting letter from an ASH member is required. (Additional mentors can be recommended by members of the study section).
• Secure a document from appropriate institutional leaders that states that at least 75 percent of the applicant’s full-time professional efforts will be devoted to research during the funded period.
• Have completed two years of training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada.
• Be a fourth or fifth-year trainee in a hematology, hematology/oncology, or hematology-related training program in the United States or Canada. Eligibility will begin on the first day of fellowship and go until five years from that date, with exceptions made for leaves of absence. Assistant professors are not eligible to apply.
• Continue to maintain ASH membership.
• Not have any other career-development funding during the award period. Including but not limited to foundation and NIH career development (K12, K23, K01 K08, T32) ASCO YIA, Leukemia and Lymphoma Society Clinical Scholar awards, etc.
• The RTAF is to be the recipients' main source of salary support. In the event that the recipient's salary is not fully covered by the Research Training Award for Fellows, supplementary funding from non career development awards or grants may be used to pay the balance of the recipients' salary.
• The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to the potential for future independent investigation and commitment to a career in hematology research.
Please Note: Any application which does not follow the stated requirements, includes additional documents outside of the required documents, is not formatted correctly, is lacking information, has incorrect information, or is lacking required documents as outlined in this document, will be deemed ineligible and will not be reviewed by the study section.
There are no appeals, or consideration for additional or further review once an application has been determined to be ineligible.
Questions regarding this application and the ASH Research Training Award for Fellows should be directed to the ASH Training Manager, at email@example.com or 202-776-0544.
Call for Applications: Cooley’s Anemia Foundation 2014-2015 Research Fellowships
The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 Research Fellowships. Postdoctoral and junior faculty members investigating clinical or basic research related to thalassemia are eligible. Applications studying iron overload, iron chelation, methods of non-invasive iron measurement, quality of life, hepatitis C, osteoporosis, fertility, bone marrow transplantation and gene therapy are encouraged. Postdoctoral fellows should hold MD, PhD or equivalent degrees and require sponsorship by a faculty mentor. Junior faculty applicants should not have held the rank of Assistant Professor for more than 5 years and must not have already received R-01 level support. Stipends will be $32,500 annually with possibility of a one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. Successful postdoctoral fellows are expected to use the funds for salary support, whereas junior faculty applicants may use funds for salary or non-salary research support. Awards will be announced in June 2014.
The completed application is due Monday, February 3, 2014.
A scanned completed application in PDF format for each application is to be e-mailed to: firstname.lastname@example.org
For further information, please contact:
Cooley’s Anemia Foundation
330 Seventh Avenue #200
New York, NY 10001
800 522 7222